Literature DB >> 20022811

Using microRNAs to understand cancer biology.

Joanne Weidhaas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20022811      PMCID： PMC5919278          DOI： 10.1016/S1470-2045(09)70386-9

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.

Authors:  George Adrian Calin; Calin Dan Dumitru; Masayoshi Shimizu; Roberta Bichi; Simona Zupo; Evan Noch; Hansjuerg Aldler; Sashi Rattan; Michael Keating; Kanti Rai; Laura Rassenti; Thomas Kipps; Massimo Negrini; Florencia Bullrich; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-14       Impact factor: 11.205

2.  Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis.

Authors:  Tetsuya Ueda; Stefano Volinia; Hiroshi Okumura; Masayoshi Shimizu; Cristian Taccioli; Simona Rossi; Hansjuerg Alder; Chang-gong Liu; Naohide Oue; Wataru Yasui; Kazuhiro Yoshida; Hiroki Sasaki; Sachiyo Nomura; Yasuyuki Seto; Michio Kaminishi; George A Calin; Carlo M Croce
Journal:  Lancet Oncol       Date:  2009-12-18       Impact factor: 41.316

3.  Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.

Authors:  Junichi Takamizawa; Hiroyuki Konishi; Kiyoshi Yanagisawa; Shuta Tomida; Hirotaka Osada; Hideki Endoh; Tomoko Harano; Yasushi Yatabe; Masato Nagino; Yuji Nimura; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701
  3 in total
  15 in total

1.  Complexity of the microRNA repertoire revealed by next-generation sequencing.

Authors:  Lik Wee Lee; Shile Zhang; Alton Etheridge; Li Ma; Dan Martin; David Galas; Kai Wang
Journal:  RNA       Date:  2010-09-28       Impact factor: 4.942

2.  miRNA-612 suppresses ovarian cancer cell tumorigenicity by downregulating NOB1.

Authors:  Zhikun Shi; Xu Zhou; Meijing Bao; Rongxia Jia; Yuqing Chu; Yang Lin
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

3.  MiR-101 regulates apoptosis of trophoblast HTR-8/SVneo cells by targeting endoplasmic reticulum (ER) protein 44 during preeclampsia.

Authors:  Y Zou; Z Jiang; X Yu; Y Zhang; M Sun; W Wang; Z Ge; W De; L Sun
Journal:  J Hum Hypertens       Date:  2014-05-08       Impact factor: 3.012

Review 4.  Peripheral biomarkers of stroke: Focus on circulatory microRNAs.

Authors:  Murali Vijayan; P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2016-08-05

Review 5.  A genetic view of laryngeal cancer heterogeneity.

Authors:  María José de Miguel-Luken; Manuel Chaves-Conde; Amancio Carnero
Journal:  Cell Cycle       Date:  2016-03-03       Impact factor: 4.534

Review 6.  TOX gene: a novel target for human cancer gene therapy.

Authors:  Xin Yu; Zheng Li
Journal:  Am J Cancer Res       Date:  2015-11-15       Impact factor: 6.166

7.  A comprehensive survey of miRNA repertoire and 3' addition events in the placentas of patients with pre-eclampsia from high-throughput sequencing.

Authors:  Li Guo; Qi Yang; Jiafeng Lu; Hailing Li; Qinyu Ge; Wanjun Gu; Yunfei Bai; Zuhong Lu
Journal:  PLoS One       Date:  2011-06-22       Impact factor: 3.240

Review 8.  The role of microRNAs expression in laryngeal cancer.

Authors:  Xin Yu; Zheng Li
Journal:  Oncotarget       Date:  2015-09-15

9.  Uncover miRNA-Disease Association by Exploiting Global Network Similarity.

Authors:  Min Chen; Xingguo Lu; Bo Liao; Zejun Li; Lijun Cai; Changlong Gu
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

10.  Walking the interactome to identify human miRNA-disease associations through the functional link between miRNA targets and disease genes.

Authors:  Hongbo Shi; Juan Xu; Guangde Zhang; Liangde Xu; Chunquan Li; Li Wang; Zheng Zhao; Wei Jiang; Zheng Guo; Xia Li
Journal:  BMC Syst Biol       Date:  2013-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.